Viva BioInnovator (VBI) is the specialized investment and incubation arm of Viva Biotech Holdings, focusing on biotech startups across all indications and drug types. They nurture and accelerate startup growth from idea to clinical program, primarily investing in seed and Series A rounds, with occasional participation in Series B funding.

VBI's portfolio includes notable companies such as Amberstone Biosciences, ArrePath, and Arthrosi Therapeutics. Their unique investment and incubation model, developed since 2014, leverages Viva Biotech's expertise in drug discovery services. VBI offers world-leading proprietary technologies and resources to support early-stage biotech companies, providing a comprehensive platform for startup development and growth.